Copaxone

Teva Pharmaceutical

Teva faced a challenge with the sales of their multiple sclerosis medication Copaxone, which physicians often prescribed as an alternative or very late in the course of treatment. Teva wanted to highlight the benefits of starting the product early and to dispel common misconceptions. For this, I designed a colourful eDetailer with interactive elements allowing physicians to compare their own views against the medical studies on the product. Physicians were also given the opportunity to calculate the potential reduction in patient sick days. The eDetailer was a great success and proved a surprising eye-opener for both physicians and patients.